Scipher Medicine
  • Contact
  • Platform
  • Solutions
  • Company
  • Latest
  • Careers
  • Contact
  • Join Us

Publications

    All articles Press Releases Publications News Articles Media Kit
    Show all Press Releases Publications News Articles Media Kit
  • Human Disease 11/4/22
    Publications
    Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis
  • dna structure 6/1/22
    Publications
    Evaluation of physician global assessment in patients with b/tsDMARD therapy selection aligned with a molecular signature response classifier: an analysis from The Study to Accelerate Information of Molecular Signatures (AIMS) in Rheumatoid Arthritis
  • Pill packs 3/29/22
    Publications
    Budget Impact and Clinical Outcomes of a Molecular Signature to Inform TNFi Treatment Selection in Commercial Patients with Rheumatoid Arthritis 
  • Human Interactome Network 3/16/22
    Publications
    Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis
  • Developing New Drug Treatments 12/30/21
    Publications
    Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritis
  • Human Interactome Network 12/1/21
    Publications
    Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility
  • Interactome 11/10/21
    Publications
    A molecular signature response classifier to predict inadequate response to tumor necrosis factor-α Inhibitors: the NETWORK-004 Prospective Observational Study
  • Human Disease 11/8/21
    Publications
    Discontinuation of TNFi treatment among Rheumatoid Arthritis patients with a molecular signature of non-response to tumor necrosis factor-ɑ inhibitor therapies
  • Blood Test 11/8/21
    Publications
    A molecular signature response classifier predicts the likelihood of non-response to TNF inhibitor therapies in RA at 3 months
  • Disease Module Detection 10/26/21
    Publications
    Analytical and clinical validation of an RNA sequencing-based assay for quantitative, accurate evaluation of a molecular signature response classifier in rheumatoid arthritis
  • Gene Mapping 10/1/21
    Publications
    A network medicine approach to discover common novel drug target mechanisms across autoimmune diseases
  • Pill packs 9/8/21
    Publications
    A molecular signature response classifier stratifies seropositive rheumatoid arthritis patients based on their likelihood of inadequate response to TNF inhibitor therapies
  • dna structure 6/10/21
    Publications
    A high-confidence definition of therapeutic response in rheumatoid arthritiss using a Monte Carlo simulation approach
  • Network 6/10/21
    Publications
    A molecular signature response classifier predicts the likelihood of eular nonresponse to TNF inhibitor therapies in RA: results from a retrospective cohort analysis
  • Lab Testing 3/30/21
    Publications
    Network medicine framework for identifying drug-repurposing opportunities for COVID-19

Posts navigation

1 2 Next
Scipher Medicine
  • Privacy Policy
  • Patient Opt-out Information
  • Notice of Privacy Practices
  • Terms of Use
  • Cookies Acknowledgement
  • Site Map
©2023 Scipher Medicine. All rights reserved.
    • Platform
    • Solutions
    • Company
    • Latest
    • Careers
    • Contact
    • Join Us